학술논문

Safety and efficacy of Daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA Foundation cohorts
Document Type
Journal
Source
JOURNAL OF HEPATOLOGY; APR 2018, 68 pS300-pS300, 1p. Supplement: 1
Subject
Language
English
ISSN
16000641